Effective 7/1/25, the Plan A and B copay for GLP-1 medications for obesity treatment is:
- 30-day supply: $150
- 90-day supply: $300
GLP-1 for obesity copays will accumulate towards the pharmacy out-of-pocket maximum and will continue to be charged after the out-of-pocket maximum has been met.
This change does not impact the copays for GLP-1 medications for diabetes. Copays for GLP-1 medications for diabetes, i.e. Ozempic, are $35 for a 30-day supply or $70 for a 90-day supply.
This change was necessary to maintain plan coverage for GLP-1 medications for obesity. Without these changes, the costs of GLP-1 medications for obesity would exceed the cost of all other medications combined in 2026. The JHMB is continuing to monitor the costs of GLP-1 medications for obesity and may make additional changes to coverage of GLP-1 medications for obesity in January 2026 to maintain the health fund balance.